Cannabist Company Holdings Inc - Asset Resilience Ratio
Cannabist Company Holdings Inc (CBST) has an Asset Resilience Ratio of 0.20% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Cannabist Company Holdings Inc (CBST) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2023)
This chart shows how Cannabist Company Holdings Inc's Asset Resilience Ratio has changed over time. See Cannabist Company Holdings Inc (CBST) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Cannabist Company Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CBST company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$1.52 Million | 0.2% |
| Total Liquid Assets | CA$1.52 Million | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Cannabist Company Holdings Inc maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cannabist Company Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Cannabist Company Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE |
Drug Manufacturers - Specialty & Generic | 1.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 20.24% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
Annual Asset Resilience Ratio for Cannabist Company Holdings Inc (2020–2023)
The table below shows the annual Asset Resilience Ratio data for Cannabist Company Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.14% | CA$1.15 Million ≈ $830.45K |
CA$823.11 Million ≈ $595.43 Million |
-0.04pp |
| 2022-12-31 | 0.18% | CA$1.81 Million ≈ $1.31 Million |
CA$994.28 Million ≈ $719.24 Million |
-0.32pp |
| 2021-12-31 | 0.51% | CA$6.96 Million ≈ $5.03 Million |
CA$1.37 Billion ≈ $994.40 Million |
+0.30pp |
| 2020-12-31 | 0.21% | CA$1.51 Million ≈ $1.09 Million |
CA$727.53 Million ≈ $526.28 Million |
-- |
About Cannabist Company Holdings Inc
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Se… Read more